December 11, 2019
Nobelpharma on December 9 launched its tympanic membrane perforation (TMP) treatment Retympa (trafermin) in Japan as the first drug to carry the indication. The drug joined the NHI price list in November, with a price tag of 32,691.30 yen, with...read more